Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Main content

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. See the 1 minute video CCBIO in a Nutshell. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

CCBIO Research School / Neuro-SysMed Research School
Doctor discussing with a patient.
May 07

CCBIONeur910: Patient and Public Involvement in Medical and Health Research, 2025

The course aims to inspire increased user participation in research trials and will present methods on how to involve user representatives. This is highly relevant to all biomedical research fields, and Patient and Public Involvement is documented to positively impact the relevance and efficacy in...

News
Collage of portrait photos of Strell, Gjertsen and Gullberg.

Support from The Norwegian Cancer Society to three of CCBIO's projects

The Norwegian Cancer Society has recently allocated their 2024 grants to current cancer research projects. Eight researchers from Bergen made the final cut, including three from CCBIO.

New doctoral work
Portrait photo of Kari Wagner-Larsen.

Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer

Kari Strøno Wagner-Larsen defended November 15, 2024 her doctoral work at the University of Bergen with the thesis "Advanced MRI for developing more personalized treatment strategies in uterine cervical cancer". Wagner-Larsen's doctoral work includes four studies showing that traditional as well as...

New doctoral work
Portrait photo of Austin Rayford.

Can cancer treatment with immune checkpoint inhibitors be improved?

Austin James Rayford completed October 11, 2024 his PhD degree at the University in Bergen with his thesis "Studies on the effect of AXL inhibition in non-small cell lung cancer".

News
The SAB members and the CCBIO management standing on the stairs outside the Solstrand Hotel.

Continuing a strong cancer research network

The 12th CCBIO Annual Symposium has recently taken place, with a program showcasing current cancer biomarker research. This was the final symposium in CCBIO’s 10-year period funded by the Research Council of Norway as a Centre of Excellence (CoE), however not the last. CCBIO will continue its core...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.